Varna, Bulgaria

Deltcho G Jelyazkov

This inventor holds 1 USPTO granted patent. Top assignee: Pharmachim. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deltcho G Jelyazkov. Retrieved from https://idiyas.com/inventor/deltcho-g-jelyazkov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deltcho G Jelyazkov: Innovator in Glaucoma Treatment

Introduction

Deltcho G Jelyazkov is a notable inventor based in Varna, Bulgaria. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique antiglaucoma composition.

Latest Patents

Deltcho G Jelyazkov holds a patent for a composition and method for treating glaucoma. This antiglaucoma composition contains as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The composition is designed for use as an ophthalmic solution, administered in therapeutic doses of 2 to 3 drops two to four times daily to warm-blooded animals suffering from glaucoma. He has 1 patent to his name.

Career Highlights

Deltcho G Jelyazkov is associated with Pharmachim, a company known for its pharmaceutical innovations. His work has focused on developing effective treatments for eye conditions, showcasing his commitment to improving patient care.

Collaborations

Deltcho has collaborated with notable colleagues, including Marko T Markov and Chavdar B Ivanov. These partnerships have contributed to the advancement of his research and the successful development of his patented solutions.

Conclusion

Deltcho G Jelyazkov's contributions to glaucoma treatment exemplify the impact of innovative thinking in medicine. His dedication to research and development continues to pave the way for advancements in ophthalmic care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…